The 21 analysts offering 12-month price forecasts for Novartis AG have a median target of 108.14, with a high estimate of 133.87 and a low estimate of 90.27. The median estimate represents a +9.76% increase from the last price of 98.52.
The current consensus among 26 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.36
Reporting Date Jan 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.